Format

Send to

Choose Destination
Thyroid. 2019 Jul 12. doi: 10.1089/thy.2018.0624. [Epub ahead of print]

Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).

Author information

1
1 Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea.
2
2 Department of Otorhinolaryngology, National Cancer Center, Goyang, Republic of Korea.
3
3 Center for Thyroid Cancer, National Cancer Center, Goyang, Republic of Korea.
4
4 Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
5
5 Korea National Institute of Health, Cheongju, Republic of Korea.
6
6 Department of Internal Medicine, National Cancer Center, Goyang, Republic of Korea.
7
7 Department of Surgery, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea.
8
8 Department of Otorhinolaryngology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
9
9 Department of Otorhinolaryngology, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea.
10
10 Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
11
11 Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Abstract

Background: In this ongoing multicenter prospective cohort study on active surveillance (AS) in low-risk papillary thyroid microcarcinoma (PTMC), we aimed to compare the quality of life (QoL) of participants based on their choice of treatment, that is, AS or immediate surgery (OP). Methods: QoL of 203 participants who chose AS and 192 participants who underwent OP was evaluated using a thyroid-specific QoL questionnaire at diagnosis and during follow-up (median 8 months). Results: The mean ages of the participants in the AS and OP groups were 47.3 ± 11.7 and 45.6 ± 10.5 years (p = 0.138), respectively, and the mean tumor sizes were 5.7 ± 1.6 and 6.5 ± 2.1 mm (p = 0.065), respectively. At baseline, significantly better psychological health (7.1 ± 1.3 vs. 6.8 ± 1.6, p = 0.023) and overall health (6.8 ± 1.2 vs. 6.5 ± 1.3, p = 0.018) were observed in the AS group than in the OP group. During follow-up, significantly better physical (7.9 ± 1.1 vs. 7.4 ± 1.2, p < 0.001), psychological (7.4 ± 1.3 vs. 6.9 ± 1.6, p = 0.004), and overall health (6.9 ± 1.0 vs. 6.5 ± 1.1, p = 0.002) were observed in the AS group than in the OP group, whereas spiritual health was comparable between the two groups. Compared with the AS group, the OP group experienced more fatigue, changes in voice and appearance, less satisfaction, and low fear of recurrence. The self-assessed financial burden was similar at baseline and follow-up in both groups. Conclusion: The QoL of PTMC patients is different according to the type of treatment. Better psychological health at baseline and physical and psychological health at follow-up were observed in the AS group than in the OP group. However, studies with longer follow-up periods are needed.

KEYWORDS:

active surveillance; papillary thyroid microcarcinoma; physical health; psychological health; quality of life

PMID:
31161898
DOI:
10.1089/thy.2018.0624

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center